Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholders??? Deficit

v3.21.2
Statements of Stockholders’ Deficit - USD ($)
$ in Thousands
Common Stock
Preferred stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 8 $ 2,766 $ (3,658) $ (884)
Balance (in Shares) at Dec. 31, 2019 8,456,179        
Net loss (unaudited)       (344) (344)
Issuance of common stock for cash (unaudited) 50   50
Issuance of common stock for cash (unaudited) (in Shares) 11,862        
Issuance of common stock for anti-dilution clause (unaudited) 2 2
Issuance of common stock for anti-dilution clause (unaudited) (in Shares) 475        
Stock-based compensation expense (unaudited) 31 31
Balance at Mar. 31, 2020 $ 8 2,849 (4,002) (1,145)
Balance (in Shares) at Mar. 31, 2020 8,468,516        
Balance at Dec. 31, 2019 $ 8 2,766 (3,658) (884)
Balance (in Shares) at Dec. 31, 2019 8,456,179        
Stock-based compensation expense (unaudited)         91
Balance at Jun. 30, 2020 $ 9 3,028 (4,340) (1,303)
Balance (in Shares) at Jun. 30, 2020 8,496,541        
Balance at Dec. 31, 2019 $ 8 2,766 (3,658) (884)
Balance (in Shares) at Dec. 31, 2019 8,456,179        
Balance at Dec. 31, 2020 $ 9 3,242 (5,922) (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070        
Balance at Mar. 31, 2020 $ 8 2,849 (4,002) (1,145)
Balance (in Shares) at Mar. 31, 2020 8,468,516        
Net loss (unaudited)   (338) (338)
Issuance of common stock for cash (unaudited) $ 1 91 92
Issuance of common stock for cash (unaudited) (in Shares) 21,401        
Issuance of common stock for anti-dilution clause (unaudited) 28 28
Issuance of common stock for anti-dilution clause (unaudited) (in Shares) 6,624        
Stock-based compensation expense (unaudited) 60 60
Balance at Jun. 30, 2020 $ 9 3,028 (4,340) (1,303)
Balance (in Shares) at Jun. 30, 2020 8,496,541        
Balance at Dec. 31, 2020 $ 9 3,242 (5,922) (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070        
Net loss (unaudited)   (964) (964)
Issuance of common stock for exercise of options (unaudited) 31   31
Issuance of common stock for exercise of options (unaudited) (in Shares) 233,819        
Stock-based compensation expense (unaudited) 202 202
Balance at Mar. 31, 2021 $ 9 3,475 (6,886) (3,402)
Balance (in Shares) at Mar. 31, 2021 8,747,889        
Balance at Dec. 31, 2020 $ 9 3,242 (5,922) $ (2,671)
Balance (in Shares) at Dec. 31, 2020 8,514,070        
Issuance of common stock for exercise of options (unaudited) (in Shares)         257,219
Stock-based compensation expense (unaudited)         $ 496
Balance at Jun. 30, 2021 $ 9 3,775 (7,986) (4,202)
Balance (in Shares) at Jun. 30, 2021 8,771,290        
Balance at Mar. 31, 2021 $ 9 3,475 (6,886) (3,402)
Balance (in Shares) at Mar. 31, 2021 8,747,889        
Net loss (unaudited) (1,100) (1,100)
Issuance of common stock for exercise of options (unaudited) 6 6
Issuance of common stock for exercise of options (unaudited) (in Shares) 23,401        
Stock-based compensation expense (unaudited) 294 294
Balance at Jun. 30, 2021 $ 9 $ 3,775 $ (7,986) $ (4,202)
Balance (in Shares) at Jun. 30, 2021 8,771,290